We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Seeks Clarity on Complex Post-Approval Submissions, EMA Survey Says
Industry Seeks Clarity on Complex Post-Approval Submissions, EMA Survey Says
The pharmaceutical industry is generally satisfied with the EMA’s redesigned post-approval procedures, but would like some clarity on how to tackle more complex filings, according to an EMA survey.